Affirm (AFRM) reported stronger-than-expected fiscal Q4 results, swinging to a profit with EPS of $0.20 and revenue of $876.42 million, significantly exceeding analyst estimates. Gross Merchandise Volume (GMV) surged 43% to $10.4 billion, driven by strategic merchant expansion and credit performance, which CEO Max Levchin stated led to operating income profitability as planned. This robust performance spurred a 15% premarket jump in shares, despite the company's Q1'26 revenue guidance midpoint falling slightly below consensus, though it projects full-year 2026 GMV to exceed $46 billion.
Affirm (AFRM) delivered a robust fiscal fourth quarter, significantly outperforming analyst expectations and achieving a key milestone by swinging to profitability. The company reported earnings per share of $0.20, starkly contrasting with analyst forecasts of $0.11 and a loss of $0.14 in the prior-year period. This bottom-line strength was driven by revenue of $876.42 million, which surpassed estimates, and a remarkable 43% year-over-year surge in Gross Merchandise Volume (GMV) to $10.4 billion. Management attributed this momentum to strategic execution, including an expanded merchant network, increased transaction frequency from direct-to-consumer products like the Affirm Card, and strong credit performance, which culminated in an operating income of $58.06 million. Despite this strong performance, which propelled the stock up 15% in pre-market trading, the company issued mixed forward guidance. Its revenue forecast for Q1 fiscal 2026, at a midpoint of $870 million, falls slightly below the consensus estimate of $882.38 million. However, the full-year fiscal 2026 GMV is projected to exceed a substantial $46 billion, suggesting the market is currently prioritizing demonstrated profitability and top-line momentum over the cautious near-term revenue outlook.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
strongly positive
Sentiment Score
0.85
Ticker Sentiment